national institute of biomedical imaging and bioengineering - listserv

Weekly NIH Funding Opportunities and Notices

NIH Guide for Grants and Contracts

April 05, 2019

Table of Contents (TOC)

Web Version

Notices

Findings of Research Misconduct
(NOT-OD-19-094)
National Institutes of Health
Notice to Extend PA-16-181 Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42)
(NOT-OD-19-095)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notice to Extend PA-16-180 Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44)
(NOT-OD-19-096)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notice of Special Interest: High-Priority Research Topic for PAR-19-070
(NOT-AG-19-012)
National Institute on Aging
Notice of NIAIDs Participation in PA-19-217 Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional)"
(NOT-AI-19-054)
National Institute of Allergy and Infectious Diseases
Notice of Budget Change in RFA-AI-19-028 Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
(NOT-AI-19-056)
National Institute of Allergy and Infectious Diseases
Notice of Correction to Award Information in RFA-CA-19-038 "Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)"
(NOT-CA-19-039)
National Cancer Institute
Request for Proposals (RFP) Notice: Preparation and Distribution of Research Drug Products
(NOT-DA-19-062)
National Institute on Drug Abuse
Notice of Change to Provide Additional Instructions for Renewal Applications for RFA-DK-18-020, Diabetes Research Centers (P30 Clinical Trial Optional)
(NOT-DK-19-014)
National Institute of Diabetes and Digestive and Kidney Diseases
NEI Notice of Participation in PA-19-129, "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)"
(NOT-EY-19-020)
National Eye Institute
NEI Notice of Participation in PA-19-116, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
(NOT-EY-19-021)
National Eye Institute
NEI Notice of Participation in PA-19-118, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)"
(NOT-EY-19-022)
National Eye Institute
NEI Notice of Participation in PA-19-192, "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)"
(NOT-EY-19-023)
National Eye Institute
Notice to update link for Scope of Products in RFA-FD-19-024 Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)"
(NOT-FD-19-010)
Food and Drug Administration
Notice of Change to Science Supported by PAR-17-340 "Collaborative Program Grant for Multidisciplinary Teams (RM1) (Clinical Trial Not Allowed)"
(NOT-GM-19-032)
National Institute of General Medical Sciences
Notice of Change to Science Supported by PAR-17-316 "Biomedical Technology Research Resource (P41)"
(NOT-GM-19-033)
National Institute of General Medical Sciences
Notice of Change to Science Supported by PAR-17-045 "Focused Technology Research and Development (R01)"
(NOT-GM-19-034)
National Institute of General Medical Sciences
Notice of Change to Science Supported by PAR-17-046 "Exploratory Research for Technology Development (R21)"
(NOT-GM-19-035)
National Institute of General Medical Sciences
Salary Limitation on AHRQ FY2019 Grants, Cooperative Agreements, and Contracts
(NOT-HS-19-013)
Agency for Healthcare Research and Quality
Notice of Special Interest: Availability of Administrative Supplements for NIMH Grants to Expand Suicide Research
(NOT-MH-19-026)
National Institute of Mental Health
Notice of Availability of Administrative Supplements for NIH Grants to Promote Implementation Research for Brain and Nervous System Disorders in Low- and Middle-Income Countries
(NOT-TW-19-003)
John E. Fogarty International Center
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke

Requests for Applications

Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed)
(RFA-AI-19-037)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed)
(RFA-DA-19-037)
National Institute on Drug Abuse
Application Receipt Date(s): May 8, 2019 and October 8, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
(RFA-DA-19-038)
National Institute on Drug Abuse
Application Receipt Date(s): May 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
(RFA-DA-19-039)
National Institute on Drug Abuse
Application Receipt Date(s): May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Linked Research Project Sites (Collaborative U01 Clinical Trial Not Allowed)
(RFA-DA-20-002)
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis, Informatics and Resource Center (U24 Clinical Trial Not Allowed)
(RFA-DA-20-003)
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DA-20-004)
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
(RFA-ES-19-007)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Basic Experimental Studies with Humans Required)
(RFA-ES-19-008)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)
(RFA-FD-19-024)
Food and Drug Administration
Application Receipt Date(s): June 3, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)
(RFA-HL-20-014)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 18, 2019, June 17, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Accelerating Medicine Partnership in Parkinsons disease (AMP PD) unbiased proteomics biofluid analysis (U01 Clinical Trials Not Allowed)
(RFA-NS-19-028)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-19-005)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-19-006)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): August 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Program Announcements

Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)
(PA-19-237)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first application due date for this FOA is June 16, 2019.
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
(PAR-19-232)
National Institute of General Medical Sciences
Application Receipt/Submission Date(s): October 8, 2019; October 8, 2020; October 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed)
(PAR-19-234)
National Institute on Aging Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) (PAR-19-235)
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) (PAR-19-236) National Institute of Mental Health Application Receipt/Submission Date(s): Standard dates apply,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18 Independent Clinical Trial Not Allowed)
(PAR-19-238)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed)
(PAR-19-239)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.
Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed)
(PAR-19-240)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 1?6, 2019.
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
(PAS-19-241)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.